The transaction agreement unreasonably limits competing transactions for Semler Scientific by imposing a significant penalty if Semler Scientific accepts a competing bid. We are investigating the conduct of the Semler Scientific board of directors, and whether they are fulfilling their fiduciary duties to all shareholders. Accessibility StatementSkip Navigation MILWAUKEE, Sept. 22, 2025 /PRNewswire/ -- The Ademi Firm is investigating Semler Scientific (Nasdaq: SMLR) for possible breaches of fiduciary duty a ...